Email
Print
The High-Intensity Artificial Sweeteners Market Size is estimated to reach $4.1 billion by 2027 and it is poised to grow at a CAGR of 2.7% over the forecast period of 2022-2027. Artificial sweeteners are synthetic sugar substitutes, that
may or may not be derived from naturally occurring substances. Due to a
higher sweetener content/index, the paramount need for artificial sweetener in
volume offers greater benefits to the manufacturers. Furthermore, substitutes
such as saccharin, aspartame, advantame and acesulfame potassium offer
alternatives in beverages since they have virtually no calories present. Due to a
rampant increase in the diabetes rate along with obesity incidence across the
globe, artificial sweeteners fulfill the right role in mitigating significant
health worries. However, leading research and findings indicating a direct role of artificial sweeteners in developing cardiovascular diseases post-consumption may impede the market growth.
High-Intensity Artificial Sweeteners Market Drivers
A Substantial Rise in the Prevalence of the Diabetic and Obese Population:
As per International Diabetes Federation, nearly 537 million adults are living with diabetes, which is predicted to reach 643 million in 2030. 541 million adults have Impaired Glucose Tolerance (IGT), which places them at high risk of type 2 diabetes. Similarly, the global obese population has been increasing at a stupendous pace which proliferates the demand for high-intensity sweeteners, such as saccharin, aspartame, neotame, advantame and others.
A Considerable Increase in Product Launches Dependent on Artificial Sweeteners Supplemented by Growing Taxes on Sugar:
According to an article published by the Massachusetts
General Hospital in August 2021, cutting down 20% of sugar from packaged foods
and 40% from beverages could prevent 2.48 million cases of cardiovascular
disease, 490,000 deaths related to cardiovascular disease and 750,000 diabetes
cases in the U.S. Additionally, according to Cargill Incorporated, the number
of artificial and natural sweetener-based products launched annually increased
from 377 products in 2009 to 5,710 in 2018.
For More Queries About "High-Intensity Artificial Sweeteners Market" @ https://www.industryarc.com/support.php?id=513493
Product Research and Subject Research
In September 2022, the French National Institute for Health
and Medical Research drew on data for a potential direct association between
higher artificial sweetener consumption and increased cardiovascular disease
risk, including heart attack and stroke. In August 2022, ACS - Chemistry for
Life highlighted phase-1 research which promises the discovery of a newer form
of artificial sweetener that is equivalent in taste profiles while largely
avoiding the ill effects of artificial sweeteners.
The Major Players in the Market Include
The Major players in the High-intensity Sweetener Market
include Tata & Lyle, DuPont, Cargill, Ajinomoto, Archers Daniel Midland
Company, Nestle S.A., Wilmar International Ltd, Ingredion Inc, Roquette Freres and JK Sucralose.
Over the years, marketers have widely increased their product reach by forming partnerships and close associations with value-chain actors, helping to command the price structure and quality of ingredients.